For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a genuine advancement . These novel therapies stabilize the transthyretin protein, preventing its destructive build-up and reducing the burden of t